UA27467C2 - ПОХІДНІ ІНДОЛУ ЯК 5-НТ<sub>1</sub> АГОНІСТИ ТА ПРОМІЖНІ СПОЛУКИ - Google Patents
ПОХІДНІ ІНДОЛУ ЯК 5-НТ<sub>1</sub> АГОНІСТИ ТА ПРОМІЖНІ СПОЛУКИInfo
- Publication number
- UA27467C2 UA27467C2 UA94105899A UA94105899A UA27467C2 UA 27467 C2 UA27467 C2 UA 27467C2 UA 94105899 A UA94105899 A UA 94105899A UA 94105899 A UA94105899 A UA 94105899A UA 27467 C2 UA27467 C2 UA 27467C2
- Authority
- UA
- Ukraine
- Prior art keywords
- present
- indole derivatives
- intermediates
- relates
- chiral carbon
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, ***e
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Abstract
Даний винахід стосується індольних похідних і їхніх проміжних сполук. Активні сполуки даного винаходу можуть бути використані для лікування мігрені і інших розладів. Даний винахід стосується похідних індолів формули (I): (І), де R1 являє собою атом водню, метил, 2-метоксиетил, * – означає перший хіральний центр, # – означає другий хіральний центр, і, крім того, даний винахід стосується фармацевтично прийнятних солей описаних сполук. Ці сполуки можуть бути використані для лікування мігрені і інших розладів. До сполук даного винаходу також відносяться всі оптичні ізомери формули (I) (наприклад, R- і S-стереоізомери при будь-якому хіральному центрі), їх рацемічні, діастереомерні або епімерні суміші.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US86473792A | 1992-04-07 | 1992-04-07 | |
PCT/US1993/001967 WO1993020073A1 (en) | 1992-04-07 | 1993-03-10 | Indole derivatives as 5-ht1 agonists |
Publications (1)
Publication Number | Publication Date |
---|---|
UA27467C2 true UA27467C2 (uk) | 2000-09-15 |
Family
ID=25343950
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UA94105899A UA27467C2 (uk) | 1992-04-07 | 1993-03-10 | ПОХІДНІ ІНДОЛУ ЯК 5-НТ<sub>1</sub> АГОНІСТИ ТА ПРОМІЖНІ СПОЛУКИ |
Country Status (26)
Country | Link |
---|---|
US (7) | US5747501A (uk) |
EP (1) | EP0635017A1 (uk) |
JP (1) | JP2644088B2 (uk) |
KR (1) | KR0179072B1 (uk) |
CN (2) | CN1050841C (uk) |
AU (1) | AU670579B2 (uk) |
BR (1) | BR9306201A (uk) |
CA (1) | CA2133413C (uk) |
CZ (1) | CZ281763B6 (uk) |
EG (1) | EG20226A (uk) |
FI (1) | FI931558A (uk) |
HR (1) | HRP930752A2 (uk) |
HU (1) | HUT64062A (uk) |
IL (1) | IL105206A (uk) |
MX (1) | MX9302011A (uk) |
MY (1) | MY108909A (uk) |
NO (1) | NO303388B1 (uk) |
NZ (1) | NZ251086A (uk) |
PL (1) | PL172405B1 (uk) |
RU (1) | RU2101283C1 (uk) |
SK (1) | SK280193B6 (uk) |
TW (1) | TW341565B (uk) |
UA (1) | UA27467C2 (uk) |
WO (1) | WO1993020073A1 (uk) |
YU (1) | YU48931B (uk) |
ZA (1) | ZA932440B (uk) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5578612A (en) * | 1990-10-15 | 1996-11-26 | Pfizer Inc. | Indole derivatives |
US5559129A (en) * | 1990-10-15 | 1996-09-24 | Pfizer Inc | Indole derivatives |
US5545644A (en) * | 1990-10-15 | 1996-08-13 | Pfizer Inc. | Indole derivatives |
US5607951A (en) * | 1990-10-15 | 1997-03-04 | Pfizer Inc | Indole derivatives |
US5559246A (en) * | 1990-10-15 | 1996-09-24 | Pfizer Inc. | Indole derivatives |
CA2133413C (en) * | 1992-04-07 | 2001-04-10 | John Eugene Macor | Indole derivatives as 5-ht1 antagonists |
ES2070087B1 (es) * | 1993-08-13 | 1996-02-16 | Pfizer | Derivados de indol |
DK0716649T3 (da) * | 1993-08-31 | 1999-02-08 | Pfizer | 5-Arylindolderivater |
JPH10501212A (ja) * | 1994-05-19 | 1998-02-03 | メルク シヤープ エンド ドーム リミテツド | 5−ht▲下1d▼−アルファ作働薬としてのインドール−3−イルアルキルのピペラジン、ピペリジンおよびテトラヒドロピリジン誘導体 |
GB9415575D0 (en) * | 1994-08-02 | 1994-09-21 | Merck Sharp & Dohme | Therapeutic agents |
GB9417310D0 (en) | 1994-08-27 | 1994-10-19 | Pfizer Ltd | Therapeutic agents |
GB9420529D0 (en) | 1994-10-12 | 1994-11-30 | Pfizer Ltd | Indoles |
GB9423682D0 (en) * | 1994-11-23 | 1995-01-11 | Merck Sharp & Dohme | Therapeutic agents |
EP0796258A1 (en) * | 1994-12-06 | 1997-09-24 | MERCK SHARP & DOHME LTD. | Azetidine, pyrrolidine and piperidine derivatives as 5ht1 receptor agonists |
PT848004E (pt) * | 1995-07-31 | 2003-07-31 | Shionogi & Co | Derivados pirrolidina tendo actividade inibidora da fosfolipase a2 |
GB9519558D0 (en) * | 1995-09-26 | 1995-11-29 | Merck Sharp & Dohme | Therapeutic agents |
US6051593A (en) * | 1997-06-20 | 2000-04-18 | Sugen, Inc. | 3-(cycloalkanoheteroarylidenyl)-2- indolinone protein tyrosine kinase inhibitors |
EP1100501A4 (en) * | 1998-06-30 | 2002-12-04 | Lilly Co Eli | PYRROLIDINE AND PYRROLIDINE DERIVATIVES INFLUENTING THE SYSTEMS ASSOCIATED WITH SEROTONIN |
US6355672B1 (en) * | 1998-08-07 | 2002-03-12 | Takeda Chemical Industries, Ltd. | Benzothiepin derivatives, process for the preparation of the same and uses thereof |
US5994352A (en) * | 1998-11-13 | 1999-11-30 | Pfizer Inc. | 5-arylindole derivatives |
US6326388B1 (en) * | 1999-12-21 | 2001-12-04 | Celgene Corporation | Substituted 1,3,4-oxadiazoles and a method of reducing TNF-alpha level |
US7041697B2 (en) * | 2002-09-12 | 2006-05-09 | Wyeth | Antidepressant cycloalkylamine derivatives of 2,3-dihydro-1,4-benzodioxan |
CA2635010A1 (en) * | 2005-12-30 | 2007-07-19 | Amjad Ali | Oxazolidinone derivatives as cetp inhibitors |
BRPI0920354A2 (pt) * | 2008-10-16 | 2017-06-27 | Addex Pharmaceuticals Sa | derivados de indol e benzomorfolina como moduladores de receptores de glutamato metabotrópicos |
US20100217013A1 (en) * | 2008-12-15 | 2010-08-26 | Wenge Li | Enantioselective process for the preparation of zolmitriptan |
JP6440625B2 (ja) | 2012-11-14 | 2018-12-19 | ザ・ジョンズ・ホプキンス・ユニバーシティー | 精神***病を処置するための方法および組成物 |
DK3447051T3 (da) * | 2016-04-28 | 2022-01-17 | Jiangsu Hengrui Medicine Co | Fremgangsmåde til fremstilling af tyrosinkinaseinhibitor og derivat deraf |
AU2021215709A1 (en) * | 2020-02-04 | 2022-09-01 | Mindset Pharma Inc. | 3-pyrrolidine-indole derivatives as serotonergic psychedelic agents for the treatment of CNS disorders |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA795239B (en) * | 1978-10-12 | 1980-11-26 | Glaxo Group Ltd | Heterocyclic compounds |
ZA815541B (en) * | 1980-08-12 | 1983-03-30 | Glaxo Group Ltd | Heterocyclic compounds |
US4689336A (en) * | 1981-01-02 | 1987-08-25 | Pfizer Inc. | Hypoglycemic 5-substituted oxazolidine 2,4-diones |
GB8600397D0 (en) * | 1986-01-08 | 1986-02-12 | Glaxo Group Ltd | Chemical compounds |
FR2601008B1 (fr) * | 1986-07-03 | 1990-03-30 | Sanofi Sa | Procede de synthese stereospecifique de derives de l'indole |
US4968707A (en) * | 1987-06-10 | 1990-11-06 | Pfizer Inc. | Oxazolidin-2-one derivatives as hypoglycemic agents |
GB8719167D0 (en) * | 1987-08-13 | 1987-09-23 | Glaxo Group Ltd | Chemical compounds |
GB8724912D0 (en) * | 1987-10-23 | 1987-11-25 | Wellcome Found | Indole derivatives |
GB8819024D0 (en) * | 1988-08-10 | 1988-09-14 | Glaxo Group Ltd | Chemical compounds |
IL96891A0 (en) * | 1990-01-17 | 1992-03-29 | Merck Sharp & Dohme | Indole-substituted five-membered heteroaromatic compounds,their preparation and pharmaceutical compositions containing them |
MC2210A1 (fr) * | 1990-06-07 | 1992-11-26 | Wellcome Found | Composes heterocycliques therapeutiques,leur utilisation et procede pour les preparer |
US5559246A (en) | 1990-10-15 | 1996-09-24 | Pfizer Inc. | Indole derivatives |
US5559129A (en) | 1990-10-15 | 1996-09-24 | Pfizer Inc | Indole derivatives |
US5607951A (en) | 1990-10-15 | 1997-03-04 | Pfizer Inc | Indole derivatives |
US5578612A (en) | 1990-10-15 | 1996-11-26 | Pfizer Inc. | Indole derivatives |
US5545644A (en) | 1990-10-15 | 1996-08-13 | Pfizer Inc. | Indole derivatives |
AU651637B2 (en) * | 1990-10-15 | 1994-07-28 | Pfizer Inc. | Indole derivatives |
US5208248A (en) * | 1991-01-11 | 1993-05-04 | Merck Sharpe & Dohme, Ltd. | Indazole-substituted five-membered heteroaromatic compounds |
SK278998B6 (sk) * | 1991-02-01 | 1998-05-06 | Merck Sharp & Dohme Limited | Deriváty imidazolu, triazolu a tetrazolu, spôsob i |
TW263508B (uk) * | 1991-02-12 | 1995-11-21 | Pfizer | |
ES2143992T3 (es) | 1991-11-25 | 2000-06-01 | Pfizer | Derivados de 5-(hetero- o carbociclilamino)-indol, su preparacion y uso como 5-ht1 agonistas. |
EP0545478A1 (en) * | 1991-12-03 | 1993-06-09 | MERCK SHARP & DOHME LTD. | Heterocyclic compounds as tachykinin antagonists |
US5409941A (en) | 1992-02-03 | 1995-04-25 | Pfizer Inc. | 5-heteroyl indole derivatives |
TW288010B (uk) | 1992-03-05 | 1996-10-11 | Pfizer | |
CA2133413C (en) * | 1992-04-07 | 2001-04-10 | John Eugene Macor | Indole derivatives as 5-ht1 antagonists |
JP2544704B2 (ja) | 1992-04-10 | 1996-10-16 | フアイザー・インコーポレイテツド | 5−ht▲下1▼アゴニストとしてのアシルアミノインド―ル誘導体 |
-
1993
- 1993-03-10 CA CA002133413A patent/CA2133413C/en not_active Expired - Fee Related
- 1993-03-10 CZ CZ942464A patent/CZ281763B6/cs not_active IP Right Cessation
- 1993-03-10 SK SK1206-94A patent/SK280193B6/sk unknown
- 1993-03-10 RU RU94045897/04A patent/RU2101283C1/ru not_active IP Right Cessation
- 1993-03-10 UA UA94105899A patent/UA27467C2/uk unknown
- 1993-03-10 WO PCT/US1993/001967 patent/WO1993020073A1/en not_active Application Discontinuation
- 1993-03-10 JP JP5517443A patent/JP2644088B2/ja not_active Expired - Fee Related
- 1993-03-10 PL PL93305555A patent/PL172405B1/pl not_active IP Right Cessation
- 1993-03-10 AU AU37898/93A patent/AU670579B2/en not_active Ceased
- 1993-03-10 EP EP93907216A patent/EP0635017A1/en not_active Ceased
- 1993-03-10 BR BR9306201A patent/BR9306201A/pt not_active Application Discontinuation
- 1993-03-10 NZ NZ251086A patent/NZ251086A/en unknown
- 1993-03-10 US US08/295,798 patent/US5747501A/en not_active Expired - Fee Related
- 1993-03-10 KR KR1019940703552A patent/KR0179072B1/ko not_active IP Right Cessation
- 1993-03-29 IL IL10520693A patent/IL105206A/en not_active IP Right Cessation
- 1993-04-02 HR HR930752A patent/HRP930752A2/hr not_active Application Discontinuation
- 1993-04-05 MY MYPI93000616A patent/MY108909A/en unknown
- 1993-04-05 ZA ZA932440A patent/ZA932440B/xx unknown
- 1993-04-05 EG EG20593A patent/EG20226A/xx active
- 1993-04-06 CN CN93105697A patent/CN1050841C/zh not_active Expired - Fee Related
- 1993-04-06 YU YU23893A patent/YU48931B/sh unknown
- 1993-04-06 FI FI931558A patent/FI931558A/fi not_active IP Right Cessation
- 1993-04-06 MX MX9302011A patent/MX9302011A/es unknown
- 1993-04-06 HU HU9301003A patent/HUT64062A/hu unknown
- 1993-04-09 TW TW082102651A patent/TW341565B/zh active
-
1994
- 1994-10-06 NO NO943762A patent/NO303388B1/no not_active IP Right Cessation
-
1998
- 1998-04-14 US US09/059,799 patent/US6150388A/en not_active Expired - Fee Related
- 1998-07-08 CN CN98116024A patent/CN1083443C/zh not_active Expired - Fee Related
-
2000
- 2000-10-23 US US09/694,387 patent/US6436957B1/en not_active Expired - Fee Related
- 2000-10-23 US US09/694,588 patent/US6465500B1/en not_active Expired - Fee Related
- 2000-10-23 US US09/694,808 patent/US6410739B1/en not_active Expired - Fee Related
- 2000-10-23 US US09/694,809 patent/US6387941B1/en not_active Expired - Fee Related
- 2000-10-23 US US09/694,394 patent/US6387937B1/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UA27467C2 (uk) | ПОХІДНІ ІНДОЛУ ЯК 5-НТ<sub>1</sub> АГОНІСТИ ТА ПРОМІЖНІ СПОЛУКИ | |
MY110226A (en) | Therapeutic heterocyclic compounds. | |
NO154089C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolderivater. | |
TW377344B (en) | Cyclobutyl substituted indole derivative, their preparation, pharmaceutical compositions containing them and their use in the prophylaxis and treatment of migraine | |
HUP9902405A2 (hu) | Szerotonin agonistát tartalmazó gyógyászati készítmények nátha és szénanátha kezelésére | |
KR880007538A (ko) | 피리다조 디아제핀 유도체 | |
TW429255B (en) | Pyrazine compounds having treatment of central nervous system diseases and disorders | |
GEP20012389B (en) | Benzoxazinone Dopamine D4 Receptor Antagonists, Pharmaceutical Composition Containing the Same and Method for Treatment of Psychosis or Schizophrenia | |
DE3687181D1 (de) | Knochengezielte inhibitoren der karbonischen anhydrase. | |
TW360650B (en) | Pyridin-2-ylmethyloxy-pyridin-5-ylcarbamoyl-indoline derivatives, a process for the preparation thereof, and a pharmaceutical composition comprising them | |
HU212269B (en) | Process for production of pharmaceutical compositions containing benzazepine compounds and the new active ingredients | |
AU3623399A (en) | Use of benzofuroxan derivatives in treating angina pectoris | |
HU893127D0 (en) | Process for the preparation of novel spiro-(imidazolidino-naphtaline) derivatives and pharmaceutical compositions containing such compounds as active ingredient | |
SE9702716D0 (sv) | Substituted phenylazacycloalkanes in the treatment of cognitive disorders | |
NO900636L (no) | Fremgangsmaate for fremstilling av indolderivater. | |
ES8707951A1 (es) | Derivados de tetrazol | |
UA34451C2 (uk) | 2,3,4,5-тетрагідро-1н-3-бензазепіни, що використовуються для лікування захворювань центральної нервової системи, спосіб їх одержання, фармацевтична композиція та спосіб лікування захворювань центральної нервової системи | |
CA2323315A1 (en) | Process for the preparation of piperidinylaminomethyl trifluoromethyl cyclic ether compounds | |
GR860739B (en) | Process for the preparation of benzene fused heterocyclic compounds | |
MY108455A (en) | Therapeutic benzazapine compounds. | |
HUT58721A (en) | Process for producing indolyl derivatives and pharmaceutical compositions containing them as active components |